alpha-Zearalenol; trans-Zearalenol; 36455-72-8; cis-Zearalenol; Zearalenol; alpha zearalenol; .alpha.-Zearalenol; 59D4EVJ5KC; 36455-71-7; CHEBI:35065; A-ZEARALENOL; (2E,7R,11S)-7,15,17-trihydroxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(18),2,14,16-tetraen-13-one; (3S,7R,11E)-7,14,16-trihydroxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-1H-2-benzoxacyclotetradecin-1-one; (4S,8R,12E)-8,16,18-trihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),12,15,17-tetraen-2-one; 1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10-octahydro-7,14,16-trihydroxy-3-methyl-, (3S,7R,11E)-; Zearalenol, alpha-; UNII-59D4EVJ5KC; alpha -Zearalenol; BIDD:ER0100; SCHEMBL109175; SCHEMBL343610; CHEMBL371463; SGCUT00105; DTXSID8022402; 1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10-octahydro-7,14,16-trihydroxy-3-methyl-; 3,4,5,6,7,8,9,10-Octahydro-7,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1-one; to_000090; ZINC4025169; NCGC00485224-01; 1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10-octahydro-7,14,16-trihydroxy-3-methyl-, (3S-(3R*,7S*,11Z))-; Q27890390; 6-(10-HYDROXY-6-OXO-TRANS-1-UNDECENYL)-.BETA.-RESORCYLIC ACID P-LACTONE; (3S,7R)-7,14,16-trihydroxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-1H-2-benzoxacyclotetradecin-1-one; 1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10-octahydro-7,14,16-trihydroxy-3-methyl-, (3S,7R)-; 1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10-octahydro-7,14,16-trihydroxy-3-methyl-, (3S-(3R*,7S*,11E))-; 2beta-Methyl-6alpha,15,17-trihydroxy-12,13-butano-1-oxacyclotetradecane-10,15(13),16,18(12)-tetraene-14-one